Market Research Logo

Simulations Plus Inc (SLP) - Financial and Strategic SWOT Analysis Review

Simulations Plus Inc (SLP) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Simulations Plus Inc (Simulations Plus) develops and markets software for drug discovery and development for the pharmaceutical and biotechnology industries. The company develops absorption, distribution, metabolism, excretion and toxicity modeling and simulation software. It provides preclinical and clinical pharmacometric consulting services to help its customers with regulatory submissions. Simulations Plus’s pharmaceutical and chemistry software is licensed to agrochemical, biotechnology, pharmaceutical and food industries, and regulatory agencies worldwide. The company offers training workshops and provides consulting services. It distributes its products and offers services in Australia, China, Europe, India, Japan, North America, New Zealand, South America, Singapore, and Taiwan. Simulations Plus is headquartered in Lancaster, California, the US.

Simulations Plus Inc Key Recent Developments

Jan 09,2018 Simulations Plus Reports First Quarter FY2018 Financial Results
Nov 30,2017 Simulations Plus Releases ADMET Predictor Version 8.5
Nov 14,2017 Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results
Oct 03,2017 Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 6
Simulations Plus Inc - Key Facts 6
Simulations Plus Inc - Key Employees 7
Simulations Plus Inc - Key Employee Biographies 8
Simulations Plus Inc - Key Operational Employees 9
Simulations Plus Inc - Major Products and Services 10
Simulations Plus Inc - History 11
Simulations Plus Inc - Company Statement 13
Simulations Plus Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Simulations Plus Inc - Business Description 15
Business Segment: Cognigen Corporation 15
Overview 15
Performance 15
Business Segment: DILIsym Services, Inc. 15
Overview 15
Performance 15
Business Segment: Simulations Plus 15
Overview 15
Performance 16
R&D Overview 16
Simulations Plus Inc - Corporate Strategy 17
Simulations Plus Inc - SWOT Analysis 18
SWOT Analysis - Overview 18
Simulations Plus Inc - Strengths 18
Simulations Plus Inc - Weaknesses 19
Simulations Plus Inc - Opportunities 20
Simulations Plus Inc - Threats 21
Simulations Plus Inc - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 – Company’s Lifesciences Financial Deals and Alliances 30
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Simulations Plus Inc, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Jan 09, 2018: Simulations Plus Reports First Quarter FY2018 Financial Results 33
Nov 30, 2017: Simulations Plus Releases ADMET Predictor Version 8.5 34
Nov 14, 2017: Simulations Plus Reports FY2017 and Fourth Quarter FY2017 Financial Results 35
Oct 03, 2017: Simulations Plus Reports Preliminary Revenues for Fourth Quarter and Fiscal Year 2017 36
Aug 31, 2017: Simulations Plus Announces Senior Management Changes 37
Aug 23, 2017: Simulations Plus Releases MembranePlus Version 2 38
Jul 10, 2017: Simulations Plus Reports Third Quarter FY2017 Financial Results 39
Jun 15, 2017: Simulations Plus Reports Record Preliminary Revenues for Third Quarter FY2017 40
Apr 20, 2017: Simulations Plus Establishes Distribution Channel in India with Electrolab 41
Apr 10, 2017: Simulations Plus Reports Second Quarter FY2017 Financial Results 42
Section 6 – Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47
List of Tables
Simulations Plus Inc, Key Facts 6
Simulations Plus Inc, Key Employees 7
Simulations Plus Inc, Key Employee Biographies 8
Simulations Plus Inc, Key Operational Employees 9
Simulations Plus Inc, Major Products and Services 10
Simulations Plus Inc, History 11
Simulations Plus Inc, Other Locations 14
Simulations Plus Inc, Subsidiaries 14
Simulations Plus Inc, Key Competitors 22
Simulations Plus Inc, Ratios based on current share price 23
Simulations Plus Inc, Annual Ratios 24
Simulations Plus Inc, Annual Ratios (Cont...1) 25
Simulations Plus Inc, Annual Ratios (Cont...2) 26
Simulations Plus Inc, Interim Ratios 28
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31
Simulations Plus Inc, Recent Deals Summary 32
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46
List of Figures
Simulations Plus Inc, Performance Chart (2013 - 2017) 27
Simulations Plus Inc, Ratio Charts 29
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30
Simulations Plus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report